awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30357011-CD084E48-AAC6-4FE1-9F16-D263D7CE6F0B
Q30357011-CD084E48-AAC6-4FE1-9F16-D263D7CE6F0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30357011-CD084E48-AAC6-4FE1-9F16-D263D7CE6F0B
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati
P2860
Q30357011-CD084E48-AAC6-4FE1-9F16-D263D7CE6F0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30357011-CD084E48-AAC6-4FE1-9F16-D263D7CE6F0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
95507dab796204bba690fb2757b1be2ac1291960
P2860
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.